Priority Medical

ACQUISITION

Longboard Pharmaceuticals Stock Soars 51%. It’s Being Bought for $2.6 Billion.
ACQUISITION

Longboard Pharmaceuticals Stock Soars 51%. It’s Being Bought for $2.6 Billion.

In a significant development in the pharmaceutical industry, Danish company H Lundbeck A/S has agreed to acquire U.S.based Longboard Pharmaceuticals in a $2.6 billion deal. This acquisition has sent Longboard Pharmaceuticals' stock soaring by over 51% in premarket trading, marking one of the most substantial gains in recent market history..

Lundbeck to acquire Longboard Pharmaceuticals in $2.6B deal
ACQUISITION

Lundbeck to acquire Longboard Pharmaceuticals in $2.6B deal

A Major Move in the World of Neuroscience and Rare Diseases In a significant development in the pharmaceutical industry, Danish company Lundbeck A/S has announced its intention to acquire U.S..

Brooklyn-based home care agency acquires the VNA of Staten Island: ‘We will do our best to continue to servic
ACQUISITION

Brooklyn-based home care agency acquires the VNA of Staten Island: ‘We will do our best to continue to servic

A New Chapter in Home Health Care: Brooklyn’s Prime Home Health Services Takes Over VNA of Staten Island STATEN ISLAND, N.Y. — A significant shift in the home health care landscape on Staten Island has occurred with the acquisition of the Visiting Nurse Association of Staten Island (VNASI) by Brooklynbased Prime Home Health Services..

Pharmaceutical

MBK Partners to Buy Alinamin Pharmaceutical From Blackstone -- Update

Title: Blackstone to Sell Alinamin Pharmaceutical to MBK Partners Subtitle: Strategic Move to Enhance Japanese Consumer Healthcare Firm's Expansion Introduction In a landmark deal, MBK Partner.

MBK Partners to Buy Alinamin Pharmaceutical From Blackstone -- Update
Pharmaceutical

Incyte closes $750M deal for Escient Pharmaceuticals

Philadelphia, PA – Incyte, a global biopharmaceutical company, has made a significant move in the pharmaceutical industry by closing a $750 million deal for Escient Pharmaceuticals, a company with a r.

Incyte closes $750M deal for Escient Pharmaceuticals

Subscribe to Our Newsletter

Stay up-to-date with our latest news, articles, and exclusive offers. Join our community and never miss an important update!

Follow Us